FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer

Cancer Letters

Volumn 361, Issue 2, 2015, Pages 240-250

  Zhang, Zhen ^a   Yang, Chao ^a   Gao, Wei ^a   Chen, Tuanhui ^a   Qian, Tingting ^a   Hu, Jun ^b   Tan, Yongjun ^a  

^a HUNAN UNIVERSITY   (China)

^b HUNAN CANCER HOSPITAL   (China)

Author keywords

Breast cancer; E cadherin transcription; EMT; FOXA2 transcription factor; ZEB2 transcription

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3BETA; UVOMORULIN; CADHERIN; FOXA2 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; REPRESSOR PROTEIN; ZEB2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CONTROLLED STUDY; E CADHERIN GENE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MIGRATION INHIBITION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPRESSOR GENE; STABLE EXPRESSION; TLE3 GENE; TRANSCRIPTION REGULATION; TUMOR GENE; ZEB2 GENE; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; MCF 7 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HETEROGRAFTS; HOMEODOMAIN PROTEINS; HUMANS; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84926117596     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.03.008     Document Type: Article

References (88)

1. Lim J., Thiery J.P. Epithelial-mesenchymal transitions: insights from development. Development 2012, 139:3471-3486.
2. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
3. Arnoux V., Nassour M., L'Helgoualc'h A., Hipskind R.A., Savagner P. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol. Biol. Cell 2008, 19:4738-4749.
4. Ikegami T., Zhang Y., Matsuzaki Y. Liver fibrosis: possible involvement of EMT. Cells Tissues Organs 2007, 185:213-221.
5. Carew R.M., Wang B., Kantharidis P. The role of EMT in renal fibrosis. Cell Tissue Res 2012, 347:103-116.
6. Tiwari N., Gheldof A., Tatari M., Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin. Cancer Biol 2012, 22:194-207.
7. Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann. Oncol 2010, 21(Suppl. 7):vii89-vii92.
8. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
9. Xue C., Plieth D., Venkov C., Xu C., Neilson E.G. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 2003, 63:3386-3394.
10. Forouzanfar M.H., Foreman K.J., Delossantos A.M., Lozano R., Lopez A.D., Murray C.J., et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011, 378:1461-1484.
11. Robson E.J., Khaled W.T., Abell K., Watson C.J. Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines. Differentiation 2006, 74:254-264.
12. Derksen P.W., Liu X., Saridin F., van der Gulden H., Zevenhoven J., Evers B., et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006, 10:437-449.
13. Mittal M.K., Singh K., Misra S., Chaudhuri G. SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. J. Biol. Chem 2011, 286:469-479.
14. Morel A.P., Lievre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008, 3. e2888.
15. Vesuna F., Lisok A., Kimble B., Raman V. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 2009, 11:1318-1328.
16. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3983-3988.
17. Brabletz T., Jung A., Spaderna S., Hlubek F., Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat. Rev. Cancer 2005, 5:744-749.
18. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
19. Lo H.W., Hsu S.C., Xia W., Cao X., Shih J.Y., Wei Y., et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 2007, 67:9066-9076.
20. Hardy K.M., Booth B.W., Hendrix M.J., Salomon D.S., Strizzi L. ErbB/EGF signaling and EMT in mammary development and breast cancer. J. Mammary Gland Biol. Neoplasia 2010, 15:191-199.
21. Wendt M.K., Smith J.A., Schiemann W.P. Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 2010, 29:6485-6498.
22. Asiedu M.K., Ingle J.N., Behrens M.D., Radisky D.C., Knutson K.L. TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res 2011, 71:4707-4719.
23. de Graauw M., van Miltenburg M.H., Schmidt M.K., Pont C., Lalai R., Kartopawiro J., et al. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:6340-6345.
24. Wei W., Liu W., Cassol C.A., Zheng W., Asa S.L., Ezzat S. The breast cancer susceptibility gene product fibroblast growth factor receptor 2 serves as a scaffold for regulation of NF-kappaB signaling. Mol. Cell. Biol 2012, 32:4662-4673.
25. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 2007, 7:415-428.
26. Schmalhofer O., Brabletz S., Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009, 28:151-166.
27. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
28. Kaestner K.H., Knochel W., Martinez D.E. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 2000, 14:142-146.
29. Besnard V., Wert S.E., Hull W.M., Whitsett J.A. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr. Patterns 2004, 5:193-208.
30. Friedman J.R., Kaestner K.H. The Foxa family of transcription factors in development and metabolism. Cell. Mol. Life Sci 2006, 63:2317-2328.
31. Arenas E. Foxa2: the rise and fall of dopamine neurons. Cell Stem Cell 2008, 2:110-112.
32. Rausa F.M., Tan Y., Zhou H., Yoo K.W., Stolz D.B., Watkins S.C., et al. Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol. Cell. Biol 2000, 20:8264-8282.
33. Halmos B., Basseres D.S., Monti S., Alo F.D., Dayaram T., Ferenczi K., et al. A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer. Cancer Res 2004, 64:4137-4147.
34. Espina A.G., Mendez-Vidal C., Moreno-Mateos M.A., Saez C., Romero-Franco A., Japon M.A., et al. Induction of Dlk1 by PTTG1 inhibits adipocyte differentiation and correlates with malignant transformation. Mol. Biol. Cell 2009, 20:3353-3362.
35. Cao L., Gibson J.D., Miyamoto S., Sail V., Verma R., Rosenberg D.W., et al. Intestinal lineage commitment of embryonic stem cells. Differentiation 2011, 81:1-10.
36. Kitamura T., Ido Kitamura Y. Role of FoxO proteins in pancreatic beta cells. Endocr. J. 2007, 54:507-515.
37. Katoh Y., Katoh M. Integrative genomic analyses on GLI2: mechanism of Hedgehog priming through basal GLI2 expression, and interaction map of stem cell signaling network with P53. Int. J. Oncol 2008, 33:881-886.
38. Chu G.C., Zhau H.E., Wang R., Rogatko A., Feng X., Zayzafoon M., et al. RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization. Endocr. Relat. Cancer 2014, 21:311-326.
39. Huss W.J., Gray D.R., Greenberg N.M., Mohler J.L., Smith G.J. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res 2005, 65:6640-6650.
40. Ozaki T., Matsubara T., Seo D., Okamoto M., Nagashima K., Sasaki Y., et al. Thyroid regeneration: characterization of clear cells after partial thyroidectomy. Endocrinology 2012, 153:2514-2525.
41. Gipp J., Gu G., Crylen C., Kasper S., Bushman W. Hedgehog pathway activity in the LADY prostate tumor model. Mol. Cancer 2007, 6:19.
42. Myatt S.S., Lam E.W. The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer 2007, 7:847-859.
43. Miyamoto K., Fukutomi T., Akashi-Tanaka S., Hasegawa T., Asahara T., Sugimura T., et al. Identification of 20 genes aberrantly methylated in human breast cancers. Int. J. Cancer 2005, 116:407-414.
44. Liu Y.N., Lee W.W., Wang C.Y., Chao T.H., Chen Y., Chen J.H. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 2005, 24:8277-8290.
45. Song Y., Washington M.K., Crawford H.C. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res 2010, 70:2115-2125.
46. Lehner F., Kulik U., Klempnauer J., Borlak J. The hepatocyte nuclear factor 6 (HNF6) and FOXA2 are key regulators in colorectal liver metastases. FASEB J. 2007, 21:1445-1462.
47. Tang Y., Shu G., Yuan X., Jing N., Song J. FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers. Cell Res 2011, 21:316-326.
48. Cirillo L.A., Lin F.R., Cuesta I., Friedman D., Jarnik M., Zaret K.S. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 2002, 9:279-289.
49. Tamplin O.J., Cox B.J., Rossant J. Integrated microarray and ChIP analysis identifies multiple Foxa2 dependent target genes in the notochord. Dev. Biol 2011, 360:415-425.
50. Kerschner J.L., Gosalia N., Leir S.H., Harris A. Chromatin remodeling mediated by the FOXA1/A2 transcription factors activates expression in intestinal epithelial cells. Epigenetics 2014, 9.
51. Sekiya T., Zaret K.S. Repression by Groucho/TLE/Grg proteins: genomic site recruitment generates compacted chromatin in vitro and impairs activator binding in vivo. Mol. Cell 2007, 28:291-303.
52. Jennings B.H., Pickles L.M., Wainwright S.M., Roe S.M., Pearl L.H., Ish-Horowicz D. Molecular recognition of transcriptional repressor motifs by the WD domain of the Groucho/TLE corepressor. Mol. Cell 2006, 22:645-655.
53. Tan G., Cheng L., Chen T., Yu L., Tan Y. Foxm1 mediates LIF/Stat3-dependent self-renewal in mouse embryonic stem cells and is essential for the generation of induced pluripotent stem cells. PLoS ONE 2014, 9. e92304.
54. Fu S., Fei Q., Jiang H., Chuai S., Shi S., Xiong W., et al. Involvement of histone acetylation of Sox17 and Foxa2 promoters during mouse definitive endoderm differentiation revealed by microRNA profiling. PLoS ONE 2011, 6. e27965.
55. Hay E.D., Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am. J. Kidney Dis 1995, 26:678-690.
56. Huber M.A., Kraut N., Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol 2005, 17:548-558.
57. Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 2001, 7:1267-1278.
58. Rosivatz E., Becker I., Specht K., Fricke E., Luber B., Busch R., et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am. J. Pathol 2002, 161:1881-1891.
59. Imamichi Y., Konig A., Gress T., Menke A. Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer. Oncogene 2007, 26:2381-2385.
60. Katoh M. Integrative genomic analyses of ZEB2: transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU/OCT, and NF-kappaB. Int. J. Oncol 2009, 34:1737-1742.
61. Foroni C., Broggini M., Generali D., Damia G. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat. Rev 2012, 38:689-697.
62. Vanharanta S., Massague J. Origins of metastatic traits. Cancer Cell 2013, 24:410-421.
63. Gao D., Vahdat L.T., Wong S., Chang J.C., Mittal V. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res 2012, 72:4883-4889.
64. Cheung K.J., Gabrielson E., Werb Z., Ewald A.J. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 2013, 155:1639-1651.
65. Tsai J.H., Donaher J.L., Murphy D.A., Chau S., Yang J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012, 22:725-736.
66. Le M.T., Hamar P., Guo C., Basar E., Perdigao-Henriques R., Balaj L., et al. miR-200-containing extracellular vesicles promote breast cancer cell metastasis. J. Clin. Invest 2014, 124:5109-5128.
67. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008, 22:894-907.
68. Hasson R.M., Briggs A., Carothers A.M., Davids J.S., Wang J., Javid S.H., et al. Estrogen receptor alpha or beta loss in the colon of Min/+mice promotes crypt expansion and impairs TGFbeta and HNF3beta signaling. Carcinogenesis 2014, 35:96-102.
69. Ang S.L. Foxa1 and Foxa2 transcription factors regulate differentiation of midbrain dopaminergic neurons. Adv. Exp. Med. Biol 2009, 651:58-65.
70. Wang K., Brems J.J., Gamelli R.L., Holterman A.X. Foxa2 may modulate hepatic apoptosis through the cIAP1 pathway. Cell. Signal 2013, 25:867-874.
71. Villacorte M., Suzuki K., Hirasawa A., Ohkawa Y., Suyama M., Maruyama T., et al. beta-Catenin signaling regulates Foxa2 expression during endometrial hyperplasia formation. Oncogene 2013, 32:3477-3482.
72. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol 2006, 7:131-142.
73. Moreno-Bueno G., Portillo F., Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008, 27:6958-6969.
74. Lombaerts M., van Wezel T., Philippo K., Dierssen J.W., Zimmerman R.M., Oosting J., et al. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br. J. Cancer 2006, 94:661-671.
75. Dumont N., Wilson M.B., Crawford Y.G., Reynolds P.A., Sigaroudinia M., Tlsty T.D. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14867-14872.
76. Fukagawa A., Ishii H., Miyazawa K., Saitoh M. deltaEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells. Cancer Med 2015, 4:125-135.
77. Sekiya T., Muthurajan U.M., Luger K., Tulin A.V., Zaret K.S. Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA. Genes Dev 2009, 23:804-809.
78. Bernstein B.E., Kamal M., Lindblad-Toh K., Bekiranov S., Bailey D.K., Huebert D.J., et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005, 120:169-181.
79. Lupien M., Eeckhoute J., Meyer C.A., Wang Q., Zhang Y., Li W., et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008, 132:958-970.
80. Eeckhoute J., Lupien M., Meyer C.A., Verzi M.P., Shivdasani R.A., Liu X.S., et al. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res 2009, 19:372-380.
81. Yu X., Li P., Roeder R.G., Wang Z. Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split. Mol. Cell. Biol 2001, 21:4614-4625.
82. Chen G., Fernandez J., Mische S., Courey A.J. A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. Genes Dev 1999, 13:2218-2230.
83. Patel S.R., Bhumbra S.S., Paknikar R.S., Dressler G.R. Epigenetic mechanisms of Groucho/Grg/TLE mediated transcriptional repression. Mol. Cell 2012, 45:185-195.
84. Chen T., He S., Zhang Z., Gao W., Yu L., Tan Y. Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells. Exp. Cell Res 2014, 326:326-335.
85. Mani S.A., Yang J., Brooks M., Schwaninger G., Zhou A., Miura N., et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:10069-10074.
86. Lindley L.E., Briegel K.J. Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells. Biochem. Biophys. Res. Commun 2010, 399:659-664.
87. Yang C., Chen H., Tan G., Gao W., Cheng L., Jiang X., et al. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer. Cancer Lett 2013, 340:104-112.
88. van den Brink G.R., Hardwick J.C., Tytgat G.N., Brink M.A., Ten Kate F.J., Van Deventer S.J., et al. Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology 2001, 121:317-328.